0000912057-01-533337.txt : 20011009
0000912057-01-533337.hdr.sgml : 20011009
ACCESSION NUMBER: 0000912057-01-533337
CONFORMED SUBMISSION TYPE: 8-K/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20010920
ITEM INFORMATION: Financial statements and exhibits
FILED AS OF DATE: 20010925
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 8-K/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 1743921
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
8-K/A
1
a2059509z8-ka.txt
FORM 8K/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
September 24, 2001
Date of Report
BRISTOL-MYERS SQUIBB COMPANY
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-1136 22-079-0350
(Commission File Number) (IRS Employer Identification Number)
345 Park Avenue, New York, NY 10154
(Address of principal executive offices) (Zip Code)
(212) 546-4000
Item 7.
This report on Form 8-K/A amends the report on Form 8-K/A filed on September 20,
2001, by substituting the following Unaudited Pro Forma Combined Balance Sheet,
June 30, 2001, for the Unaudited Pro Forma Balance Sheet, June 30, 2001,
originally filed. The only change is the historical number for DuPont
Pharmaceuticals for the line item "Excess of cost over net tangible assets
arising from business acquisitions."
Dated: September 24, 2001 BRISTOL-MYERS SQUIBB COMPANY
By: /s/ CURTIS L. TOMLIN
---------------------------------
Curtis L. Tomlin
Vice President and Controller
UNAUDITED PRO FORMA COMBINED BALANCE SHEET
JUNE 30, 2001
(DOLLARS IN MILLIONS)
HISTORICAL
-----------------------------
PRO ADJUSTED
BRISTOL-MYERS DUPONT FORMA PRO PRO
SQUIBB PHARMACEUTICALS ADJUSTMENT FORMA CLAIROL FORMA
-------- --------------- ---------- -------- -------- --------
(J)
Assets
Current Assets:
Cash and cash equivalents $ 2,944 $- $ (1,300)(F) $ 1,644 $ 2,450 $ 4,094
Time deposits and marketable securities 204 5 -- 209 -- 209
Receivables, net of allowances 3,551 273 -- 3,824 (318) 3,506
Inventories 1,909 188 160 (G) 2,257 (187) 2,070
Prepaid expenses 911 18 -- 929 (33) 896
-------- -------- -------- -------- -------- --------
Total Current Assets 9,519 484 (1,140) 8,863 1,912 10,775
Property, Plant and Equipment, net 4,681 374 -- 5,055 (213) 4,842
Insurance Recoverable 201 -- -- 201 -- 201
Excess of cost over net tangible assets
arising from business acquisitions 1,400 1,033 4,028 (G) 5,428 (44) 5,384
(1,033)(I)
Other Assets 1,675 106 2,200 (G) 5,037 (10) 5,027
334 (G)
722 (H)
-------- -------- -------- -------- -------- --------
Total Assets $ 17,476 $ 1,997 $ 5,111 $ 24,584 $ 1,645 $ 26,229
======== ======== ======== ======== ======== ========
Liabilities
Current Liabilities:
Short-term borrowings $ 162 $ 5 $ 2,500 (F) $ 2,667 ($ 2,500) 167
Accounts payable 1,629 59 -- 1,688 (152) 1,536
Accrued expenses 2,770 324 995 (G) 4,089 96 4,185
U.S. and foreign income taxes payable 700 4 -- 704 1,678 2,382
-------- -------- -------- -------- -------- --------
Total Current Liabilities 5,261 392 3,495 9,148 (878) 8,270
Other Liabilities 1,374 243 155 (G) 1,772 (28) 1,744
Long-Term Debt 1,302 1 4,000 (F) 5,303 -- 5,303
-------- -------- -------- -------- -------- --------
Total Liabilities 7,937 636 7,650 16,223 (906) 15,317
Stockholders' Equity
Net Assets Acquired -- 1,361 (1,033)(I) -- -- --
(328)(I)
Common Stock 220 -- -- 220 -- 220
Capital in excess of par value of stock 2,201 -- -- 2,201 -- 2,201
Other Comprehensive Income (1,047) -- -- (1,047) 51 (996)
Retained earnings 19,246 -- (1,900)(G) 18,068 2,500 20,568
722 (H)
-------- -------- -------- -------- -------- --------
20,620 1,361 (2,539) 19,442 2,551 21,993
Less cost of treasury stock 11,081 -- -- 11,081 -- 11,081
Total Stockholders' Equity 9,539 1,361 (2,539) 8,361 2,551 10,912
-------- -------- -------- -------- -------- --------
Total Liabilities and
Stockholders' Equity $ 17,476 $ 1,997 $ 5,111 $ 24,584 $ 1,645 $ 26,229
======== ======== ======== ======== ======== ========
See Notes to Unaudited Pro Forma Financial Statements
39